Can low-molecular-weight heparins improve outcome in patients with cancer?

This publication has 12 references indexed in Scilit:

• Variation in Relative Risk of Venous Thromboembolism in Different Cancers
  Thrombosis and Haemostasis, 2002
• Effects of a Low-Molecular-Weight Heparin on Thrombus Regression and Recurrent Thromboembolism in Patients with Deep-Vein Thrombosis
  New England Journal of Medicine, 2001
• Prevention of Venous Thromboembolism
  Chest, 2001
• Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims Data
  Medicine, 1999
• Role of tissue factor expression on tumour cell invasion and growth of experimental pancreatic adenocarcinoma
  British Journal of Surgery, 1999
• Do Heparins Do More than Just Treat Thrombosis? The Influence of Heparins on Cancer Spread
  Thrombosis and Haemostasis, 1999
• Tissue factor in cancer angiogenesis and metastasis
  Current Opinion in Hematology, 1996
• Subcutaneous heparin treatment increases survival in small cell lung cancer
  Cancer, 1994
• Prevalence of pulmonary embolism at necropsy in patients with cancer.
  Journal of Clinical Pathology, 1989
• Fatal Pulmonary Embolism in Cancer Patients
  Southern Medical Journal, 1980